TriSalus Life Sciences Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, TriSalus Life Sciences stock has a consensus rating of "Strong Buy" and an average price target of $10.4. The average 1-year stock price forecast is 186.50% higher than the current stock price, while the lowest is $7.00 (+92.84%) and the highest is $14 (+285.67%).

Price Target: $10.4 (+186.50%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$7.00	$10.4	$11	$14
Change	+92.84%	+186.50%	+203.03%	+285.67%

Analyst Ratings

The average analyst rating for TriSalus Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Apr '26	May '26	Jun '26	Jul '26	Aug '26	Sep '26
Strong Buy	4	4	4	3	3	4
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	4	4	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Swayampakula Ramakanth H.C. Wainwright	H.C. Wainwright	Buy Reiterates $12	Buy	Reiterates	$12	+230.58%	Oct 1, 2026
Frank Takkinen Lake Street	Lake Street	Buy Reiterates $8	Buy	Reiterates	$8	+120.39%	Sep 23, 2026
William Plovanic Canaccord Genuity	Canaccord Genuity	Buy Maintains $7	Buy	Maintains	$7	+92.84%	Sep 23, 2026
Jason McCarthy Maxim Group	Maxim Group	Buy Reiterates $10 → $14	Buy	Reiterates	$10 → $14	+285.67%	Aug 11, 2026
Justin Walsh JonesTrading	JonesTrading	Buy Reiterates $11	Buy	Reiterates	$11	+203.03%	Aug 10, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

53.12M

from 45.15M

17.65%

from 45.15M

Revenue Next Year

74.51M

from 53.12M

40.27%

from 53.12M

EPS This Year

-0.45

EPS Next Year

-0.25

from -0.45

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	8.40M	12.40M	18.51M	29.43M	45.15M	53.12M
Revenue Growth	54.60%	47.58%	49.31%	58.99%	53.41%	17.65%
Gross Profit	7.21M	10.14M	15.91M	25.33M	38.19M	45.98M
Gross Margin	85.80%	81.79%	85.93%	86.06%	84.57%	86.57%
Operating Income	-24.03M	-36.44M	-50.18M	-36.17M	-26.95M	-27.36M
Net Income	-28.85M	-47.19M	-59.36M	-30.05M	-39.23M	-19.00M
EPS	-	-	-	-	-	-0.45
Free Cash Flow	-	-	-	-	-18.93M	-8.52M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	55.5M
Avg	53.1M
Low	49.1M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	23.0%
Avg	17.6%
Low	8.7%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.45
Avg	-0.45
Low	-0.45

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-